FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2889944751> ?p ?o ?g. }

• W2889944751 endingPage "1029" @default.
• W2889944751 startingPage "1029" @default.
• W2889944751 abstract "Retention in addiction treatment is associated with reduced mortality for individuals with opioid use disorder (OUD). Although clinical trials support use of OUD medications among youths (adolescents and young adults), data on timely receipt of buprenorphine hydrochloride, naltrexone hydrochloride, and methadone hydrochloride and its association with retention in care in real-world treatment settings are lacking.To identify the proportion of youths who received treatment for addiction after diagnosis and to determine whether timely receipt of OUD medications is associated with retention in care.This retrospective cohort study used enrollment data and complete health insurance claims of 2.4 million youths aged 13 to 22 years from 11 states enrolled in Medicaid from January 1, 2014, to December 31, 2015. Data analysis was performed from August 1, 2017, to March 15, 2018.Receipt of OUD medication (buprenorphine, naltrexone, or methadone) within 3 months of diagnosis of OUD compared with receipt of behavioral health services alone.Retention in care, with attrition defined as 60 days or more without any treatment-related claims.Among 4837 youths diagnosed with OUD, 2752 (56.9%) were female and 3677 (76.0%) were non-Hispanic white. Median age was 20 years (interquartile range [IQR], 19-21 years). Overall, 3654 youths (75.5%) received any treatment within 3 months of diagnosis of OUD. Most youths received only behavioral health services (2515 [52.0%]), with fewer receiving OUD medications (1139 [23.5%]). Only 34 of 728 adolescents younger than 18 years (4.7%; 95% CI, 3.1%-6.2%) and 1105 of 4109 young adults age 18 years or older (26.9%; 95% CI, 25.5%-28.2%) received timely OUD medications. Median retention in care among youths who received timely buprenorphine was 123 days (IQR, 33-434 days); naltrexone, 150 days (IQR, 50-670 days); and methadone, 324 days (IQR, 115-670 days) compared with 67 days (IQR, 14-206 days) among youths who received only behavioral health services. Timely receipt of buprenorphine (adjusted hazard ratio, 0.58; 95% CI, 0.52-0.64), naltrexone (adjusted hazard ratio, 0.54; 95% CI, 0.43-0.69), and methadone (adjusted hazard ratio, 0.32; 95% CI, 0.22-0.47) were each independently associated with lower attrition from treatment compared with receipt of behavioral health services alone.Timely receipt of buprenorphine, naltrexone, or methadone was associated with greater retention in care among youths with OUD compared with behavioral treatment only. Strategies to address the underuse of evidence-based medications for youths with OUD are urgently needed." @default.
• W2889944751 created "2018-09-27" @default.
• W2889944751 creator A5003133082 @default.
• W2889944751 creator A5015392464 @default.
• W2889944751 creator A5024054232 @default.
• W2889944751 creator A5030743581 @default.
• W2889944751 creator A5039633744 @default.
• W2889944751 creator A5041921767 @default.
• W2889944751 creator A5064867340 @default.
• W2889944751 creator A5073491656 @default.
• W2889944751 date "2018-11-01" @default.
• W2889944751 modified "2023-10-13" @default.
• W2889944751 title "Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder" @default.
• W2889944751 cites W1982621702 @default.
• W2889944751 cites W1991819836 @default.
• W2889944751 cites W1992227982 @default.
• W2889944751 cites W2011421419 @default.
• W2889944751 cites W2030329606 @default.
• W2889944751 cites W2049229004 @default.
• W2889944751 cites W2050873002 @default.
• W2889944751 cites W2051968567 @default.
• W2889944751 cites W2075040951 @default.
• W2889944751 cites W2087217077 @default.
• W2889944751 cites W2109770916 @default.
• W2889944751 cites W2117974325 @default.
• W2889944751 cites W2125637902 @default.
• W2889944751 cites W2146443350 @default.
• W2889944751 cites W2164375280 @default.
• W2889944751 cites W2164678034 @default.
• W2889944751 cites W2287000876 @default.
• W2889944751 cites W2346488245 @default.
• W2889944751 cites W2404633355 @default.
• W2889944751 cites W2541835936 @default.
• W2889944751 cites W2564687864 @default.
• W2889944751 cites W2566316894 @default.
• W2889944751 cites W2593295944 @default.
• W2889944751 cites W2597558499 @default.
• W2889944751 cites W2608446001 @default.
• W2889944751 cites W2611486992 @default.
• W2889944751 cites W2626978912 @default.
• W2889944751 cites W2703647838 @default.
• W2889944751 cites W2736062301 @default.
• W2889944751 cites W2743004910 @default.
• W2889944751 cites W2743294273 @default.
• W2889944751 cites W2746461211 @default.
• W2889944751 cites W2747986097 @default.
• W2889944751 cites W282431559 @default.
• W2889944751 cites W4238295844 @default.
• W2889944751 cites W789546000 @default.
• W2889944751 cites W86137910 @default.
• W2889944751 doi "https://doi.org/10.1001/jamapediatrics.2018.2143" @default.
• W2889944751 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6218311" @default.
• W2889944751 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30208470" @default.
• W2889944751 hasPublicationYear "2018" @default.
• W2889944751 type Work @default.
• W2889944751 sameAs 2889944751 @default.
• W2889944751 citedByCount "127" @default.
• W2889944751 countsByYear W28899447512018 @default.
• W2889944751 countsByYear W28899447512019 @default.
• W2889944751 countsByYear W28899447512020 @default.
• W2889944751 countsByYear W28899447512021 @default.
• W2889944751 countsByYear W28899447512022 @default.
• W2889944751 countsByYear W28899447512023 @default.
• W2889944751 crossrefType "journal-article" @default.
• W2889944751 hasAuthorship W2889944751A5003133082 @default.
• W2889944751 hasAuthorship W2889944751A5015392464 @default.
• W2889944751 hasAuthorship W2889944751A5024054232 @default.
• W2889944751 hasAuthorship W2889944751A5030743581 @default.
• W2889944751 hasAuthorship W2889944751A5039633744 @default.
• W2889944751 hasAuthorship W2889944751A5041921767 @default.
• W2889944751 hasAuthorship W2889944751A5064867340 @default.
• W2889944751 hasAuthorship W2889944751A5073491656 @default.
• W2889944751 hasBestOaLocation W28899447511 @default.
• W2889944751 hasConcept C118552586 @default.
• W2889944751 hasConcept C119060515 @default.
• W2889944751 hasConcept C126322002 @default.
• W2889944751 hasConcept C136764020 @default.
• W2889944751 hasConcept C160735492 @default.
• W2889944751 hasConcept C162324750 @default.
• W2889944751 hasConcept C170493617 @default.
• W2889944751 hasConcept C205545832 @default.
• W2889944751 hasConcept C2776534028 @default.
• W2889944751 hasConcept C2777972943 @default.
• W2889944751 hasConcept C2778767360 @default.
• W2889944751 hasConcept C2778949969 @default.
• W2889944751 hasConcept C2778979077 @default.
• W2889944751 hasConcept C2779418921 @default.
• W2889944751 hasConcept C2781063702 @default.
• W2889944751 hasConcept C41008148 @default.
• W2889944751 hasConcept C48856860 @default.
• W2889944751 hasConcept C50522688 @default.
• W2889944751 hasConcept C71924100 @default.
• W2889944751 hasConceptScore W2889944751C118552586 @default.
• W2889944751 hasConceptScore W2889944751C119060515 @default.
• W2889944751 hasConceptScore W2889944751C126322002 @default.
• W2889944751 hasConceptScore W2889944751C136764020 @default.
• W2889944751 hasConceptScore W2889944751C160735492 @default.
• W2889944751 hasConceptScore W2889944751C162324750 @default.

• next